Fresh Day Meds review

What it is

Fresh Day Meds, LLC is a Houston, Texas telehealth platform operating across weight loss, longevity, sexual wellness, hair health and testosterone support on a single account. Its longevity line carries an NAD⁺ injection and MIC+B12; its testosterone-support line carries enclomiphene tablets; its weight line carries compounded semaglutide and tirzepatide. Clinical care is delivered through Telegra MD LLC of Spokane, Washington, named on its own terms. It is LegitScript certified and HIPAA compliant, publishes a Houston street address, advertises free expedited shipping and prescription review in under four hours, and states no membership requirement with cancel-anytime terms.

How it works

Asynchronous and fast, with an unusual amount of published identity behind it. You complete an intake, a prescriber from the affiliated medical group reviews it, and medication ships free and expedited; the platform advertises prescription review in under four hours. Naming Telegra MD as the medical group is a meaningful disclosure — most competitors describe an anonymous clinician network — even though a white-label medical group is itself a standard arrangement rather than a distinguishing one. The state position needs care: the Terms of Service enumerate 49 states plus DC, omitting Arkansas, while the About page claims all 50 plus DC. We treat the Terms as the operative list, and anyone in Arkansas should confirm directly. What Fresh Day does not publish is the compounding pharmacy, described only as state-licensed 503A and 503B facilities, and it names neither a medical director nor a founder. There is no lab work in the default path either, which is the usual position for this board but still worth stating.

Pricing transparency

Published for both of the molecules this batch cares about here. The NAD⁺ longevity injection is from $159 a month and enclomiphene is from $149 a month, both figures live on the site and neither present in the record we started from. On the weight side, compounded semaglutide runs $133 a month on a three-month bundle billed at $399 or $160 for a single month, and tirzepatide $166 on a three-month bundle billed at $499 or $199 for one month — those are GLP-1 prices and are irrelevant to an NAD⁺ decision except as evidence that this platform prices in plan-length bundles rather than by dose. Both peptide figures are "from" prices, so confirm what dose and volume the monthly rate supplies and whether it changes as the dose escalates, since dose-specific pricing is not shown anywhere before checkout. The company states no membership requirement, transparent pricing with no hidden fees, and cancellation at any time, and free expedited shipping is included.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Fresh Day describes state-licensed 503A and 503B compounding facilities but names no pharmacy, and compounded sterile products are not reviewed by FDA for purity and potency the way approved drugs are. On the evidence, the NAD⁺ injection is the weaker of its two relevant products by a distance: there are no controlled human outcome trials for injected NAD⁺, and the single human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears from plasma quickly. The NAD⁺ forms with human trial data are the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a raised biomarker, not a demonstrated clinical outcome. Enclomiphene deserves separating from its category label. Fresh Day files it under testosterone support, and it is not testosterone: it is a selective oestrogen receptor modulator that raises endogenous testosterone by increasing LH and FSH, with a different side-effect and monitoring profile from exogenous testosterone and, importantly, without the suppression of sperm production that testosterone causes. Anyone arriving here expecting injectable testosterone, a gel or a pellet will not find one. On the GLP-1 side the platform is compounded-only, with no brand-name fallback. Individual results vary.

Pros and watch-outs

The evidence behind what Fresh Day Meds prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Enclomiphene: the evidence for restoring testosterone without replacing it

  Randomized trials, including two Phase III RCTs, show enclomiphene restores a man's own testosterone while preserving fertility — but it was never FDA-approved.

How Fresh Day Meds compares

A few alternatives worth a look, depending on what you’re optimizing for.

• TNTru Niagen

  The most clinically-studied oral NAD⁺ precursor (NR)

  See Tru Niagen →
• RBRenue By Science

  Liposomal/sublingual NMN with posted lab testing

  See Renue By Science →
• DHDrip Hydration

  At-home / concierge NAD⁺ IV infusions

  See Drip Hydration →